Jushi Holdings (JUSHF) Accounts Payables (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Accounts Payables of $22.6 million for Q2 2026, up 29.89% year-over-year from $17.4 million in Q2 2025, and down 3.55% quarter-over-quarter from $23.4 million in Q1 2026.
Jushi Holdings (JUSHF) Accounts Payables (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Accounts Payables for 6 consecutive years, with $22.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accounts Payables rose 29.89% year-over-year to $22.6 million; the TTM figure through Jun 2026 stood at $22.6 million (up 29.89% YoY), while the FY2025 annual figure was $22.3 million, up 4.06% from the prior year.
- Accounts Payables eased to $22.6 million in Q2 2026 per JUSHF's latest filing, from $23.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $24.9 million in Q1 2023 and bottomed at $14.1 million in Q2 2022.
- Historically, Accounts Payables has averaged $19.8 million across 5 years, with a median of $20.4 million in 2023.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 102.23% — and 2024, when it slumped 31.99%.
- Jushi Holdings' Accounts Payables stood at $21.3 million in 2022, then dropped by 27.82% to $15.4 million in 2023, then soared by 39.5% to $21.5 million in 2024, then grew by 4.06% to $22.3 million in 2025, then grew by 1.07% to $22.6 million in 2026.
- Business Quant data shows JUSHF's Accounts Payables at $22.6 million in Q2 2026, $23.4 million in Q1 2026, and $22.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 22.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.57 Mn |
| Mar 31, 2026 | 23.40 Mn |
| Dec 31, 2025 | 22.33 Mn |
| Sep 30, 2025 | 20.21 Mn |
| Jun 30, 2025 | 17.38 Mn |
| Mar 31, 2025 | 20.47 Mn |
| Dec 31, 2024 | 21.46 Mn |
| Sep 30, 2024 | 20.11 Mn |
| Jun 30, 2024 | 16.04 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Dec 31, 2023 | 15.38 Mn |
| Sep 30, 2023 | 20.36 Mn |
| Jun 30, 2023 | 21.61 Mn |
| Mar 31, 2023 | 24.87 Mn |
| Dec 31, 2022 | 21.31 Mn |
| Sep 30, 2022 | 18.06 Mn |
| Jun 30, 2022 | 14.05 Mn |
| Dec 31, 2021 | 10.54 Mn |